Cargando…
Suppression of experimental uveitis by a recombinant adeno-associated virus vector encoding interleukin-1 receptor antagonist
PURPOSE: To evaluate the potential of gene therapy with a recombinant adeno-associated virus vector encoding the interleukin-1 receptor antagonist gene (rAAV-IL-1Ra) in the treatment of experimental uveitis. METHODS: The vitreal cavity of New Zealand white rabbits was injected with rAAV-IL-1Ra (4×10...
Autores principales: | Tsai, Ming-Ling, Horng, Chi-Ting, Chen, Show-Li, Xiao, Xiao, Wang, Chih-Hung, Tsao, Yeou-Ping |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723168/ https://www.ncbi.nlm.nih.gov/pubmed/19693263 |
Ejemplares similares
-
Reduction of experimental diabetic vascular leakage by delivery of angiostatin with a recombinant adeno-associated virus vector
por: Shyong, Mong-Ping, et al.
Publicado: (2007) -
Production and Titering of Recombinant Adeno-associated Viral Vectors
por: McClure, Christina, et al.
Publicado: (2011) -
Manufacturing of recombinant adeno-associated viral vectors for clinical trials
por: Clément, Nathalie, et al.
Publicado: (2016) -
Advances in Recombinant Adeno-Associated Virus Vectors for Neurodegenerative Diseases
por: Li, Leyao, et al.
Publicado: (2023) -
Manufacturing of recombinant adeno-associated viral vectors: new technologies are welcome
por: Ayuso, Eduard
Publicado: (2016)